// App-Quantinova.ai

: Ykl-40 and phenotyping of severe asthma

Researchers

Presenter

  • Margarida Castro

Principal Investigators

  • Gabrielle Lockett

  • Laurie Lau

  • Clair Barber

  • Elliott Scott

  • Thomas Brown

  • Anoop Chauhan

  • Peter Howarth

  • John Holloway

Medical Centers

  • CHLN-HSM-ImmunoAllergy; Lisbon Medical School, Lisbon, Portugal

  • Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom

  • Academic Unit of Cancer Sciences Faculty of Medicine, University of Southampton,Southampton, United Kingdom

  • Portsmouth Hospital NHS Trust, Portsmouth, United Kingdom

  • Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton; Southampton NIHR Respiratory Biomedical Research Unit, Southampton, United Kingdom

  • Human Development & Health, Faculty of Medicine, University of Southampton ; Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom

Locations

  • Portugal

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Chitinase 3 Like 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A